Cellectis - ADR
CLLS
Get informed when a big investor buys or sells
+ FollowMarket Cap$310.29M
Close$
$-1.33
143.1% downside
Current Fair Value
143.1% downsideOvervalued by 143.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $310.29 Million |
|---|---|
| Enterprise Value | $476.95 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.68 |
| Beta | 2.75 |
| Outstanding Shares | 100,527,276 |
Return
| Return on Equity | -113.16% |
|---|---|
| Return on Assets | -23.45% |
| Return on Invested Capital | -34.73% |
Valuation & Multiples
| P/E Ratio | -4.79 |
|---|---|
| PEG | 290.76 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 6.98 |
| Enterprise Value to EBIT | -8.88 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0.42 |
| Debt to Equity | 3.37 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 18, 2026
EPS Estimate
$-0.26
Average shareholder expectationRevenue Estimate
$11.04 M
Average shareholder expectationNext Earnings Call
Expected Date
July 30, 2026
EPS Estimate
$-0.29
Average shareholder expectationRevenue Estimate
$12.09 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 10.23%▼ 0.29% |
|---|---|
| Total Invested | $32.52M▼ 36.30% |
| Investors Holding | 33▼ 1.00% |
ESG Score
No data
About Cellectis
CEO: Andre Choulika